Patients with critical illnesses such as sepsis, acute respiratory distress syndrome (ARDS), and trauma who show signs of immune cell dysregulation face considerably higher risks of severe infection and death, according to research published in Nature Medicine.
The study identified a specific pattern of immune cell dysfunction-characterized by reduced levels of certain immune cells and impaired function of others-that correlated with worse outcomes in critically ill patients. Researchers found that these immune deficiencies left patients vulnerable to secondary infections, prolonged hospital stays, and increased mortality.
“Our findings highlight the critical importance of understanding the immune status of critically ill patients,” saeid the lead author of the study. “By identifying these specific immune cell defects, we can possibly develop targeted therapies to restore immune function and improve patient outcomes.”
The research team believes that this discovery could lead to new diagnostic tools to identify patients at high risk of infection and guide treatment decisions. Potential therapeutic strategies include immune-boosting therapies, such as cytokine administration or adoptive cell transfer, to help restore immune function in critically ill patients.
Further research is needed to validate these findings in larger patient cohorts and to determine the optimal strategies for restoring immune function in this vulnerable population. Though, this study represents a significant step forward in understanding the complex interplay between critical illness and the immune system.
New Framework Could Help Predict Outcomes in Critically Ill Patients
A new framework for categorizing patients based on their immune response could help clinicians predict which individuals are most likely to develop severe complications or die from critical illness, according to a
!Doctor talking to patient and family | Image credit: DC Studio – stock.adobe.com
Researchers proposed integrating Hi-DEF with triverity.| Image credit: DC Studio – stock.adobe.com
A framework for Stratifying Patients
The findings support a new Human Immune Dysregulation Evaluation Framework (Hi-DEF), according to researchers, which categorizes patients into 4 immune states: myeloid dysregulation, lymphoid dysregulation, systemwide dysregulation, or balanced response.1 Each category reflects a distinct profile of protective vs detrimental immune activity.
Patients with abnormal dysregulation on either axis were found to have a sevenfold higher likelihood of requiring ICU care or dying within 30 days compared with patients showing balanced responses (OR, 7.1; 95% CI, 5.6-8.9; *P* < 2.2 × 10-16). Hi-DEF generalized across multiple conditions, including sepsis, ARDS, trauma, and burns, suggesting a common mechanism underlying critical illness.
New Immune ‘Signature’ framework Could Improve Critical Illness Treatment
A new framework called Hi-DEF (Host-pathogen Dynamics of Early Failure) is offering a more detailed understanding of immune system dysfunction in critically ill patients, potentially leading to more precise and effective treatments. Researchers at Stanford Medicine and other institutions have identified distinct immune cell “signatures” that can differentiate between bacterial and viral infections and even predict the severity of illness. The findings were published in Nature Medicine on September 30, 2025. [1]
Traditionally, diagnosing and treating critical illnesses like sepsis has been challenging due to the complexity of the immune response.Hi-DEF analyzes patterns of immune cell activity – specifically, how diffrent immune cells interact and change in the early stages of critical illness – to provide a more nuanced picture of what’s happening within a patient’s body.
“This is a significant step towards precision medicine in the ICU,” explained Dr. Adrian Moore, lead author of the study. “By identifying these immune signatures, we can potentially tailor treatments to the specific needs of each patient, rather than relying on a one-size-fits-all approach.”
The research team found that Hi-DEF could distinguish between infections caused by bacteria and viruses, which frequently enough present with similar symptoms. Moreover, the framework showed promise in predicting which patients were likely to develop severe complications. This could allow clinicians to intervene earlier and more aggressively in those at highest risk.
Though, the researchers emphasize that Hi-DEF is still in its early stages of development. While the initial findings are promising, further research is needed to validate the framework’s accuracy and effectiveness in larger, prospective clinical trials. They caution that more studies are required to confirm treatment-specific benefits.[1, 2]
“Hi-DEF provides a launching point for further prospective multi-omic investigations into critical illness immunobiology, and also a more readily translatable, biology-based schema for developing precision medicine tools in the ICU,” the researchers said. [1]
References:
1]Moore AR, Zheng H, Ganesan A, et al. A consensus immune dysregulation framework for sepsis and critical illnesses. Nat Med. Published online September 30, 2025.[https://doiorg/101038/s41591-025-03956-5[https://doiorg/101038/s41591-025-03956-5
2]kay C. Immune cell ‘signatures’ could help guide treatment for critically ill patients. News release. Stanford Medicine. September 30, 2025.[https://medstanfordedu/news/stanford-medicine/2025/09/30/immune-cell-signatures-guide-treatment-critically-ill-patientshtml[https://medstanfordedu/news/stanford-medicine/2025/09/30/immune-cell-signatures-guide-treatment-critically-ill-patientshtml